BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Namasivayam V, Palaniappan S, Vanangamudi M. Repurposing drugs targeting epidemic viruses. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vignot S, Dhanani A, Sainte-marie I, de Ligniville Lajavardi L, Even G, Echemann M, Hulin N, Ménoret C, Maison P, Ratignier-carbonneil C. Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority. Front Pharmacol 2022;13:972660. [DOI: 10.3389/fphar.2022.972660] [Reference Citation Analysis]
2 Zhan P, Yu B, Ouyang L. Drug repurposing: An effective strategy to accelerate contemporary drug discovery. Drug Discov Today 2022:S1359-6446(22)00217-3. [PMID: 35661705 DOI: 10.1016/j.drudis.2022.05.026] [Reference Citation Analysis]